Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FCRG6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,021
Award facts
- Contract value 100% obligated
- $17,021.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,021.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Xtandi 80 mg. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal pharmaceutical procurement. The award was issued under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support the Department of Defense's pharmaceutical supply requirements across military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the military medical supply chain, with a track record of delivering diverse pharmaceutical products including oncology treatments, biologics, vaccines, and specialty medications to support DoD healthcare operations. The contractor's performance on numerous delivery orders across multiple therapeutic categories, combined with its established presence in the federal pharmaceutical market since 2001, positions it as a capable regional prime vendor contractor under the PPV-G GEN V program, which authorizes delivery orders for comprehensive ranges of branded and generic prescription drugs, over-the-counter medications, and medical consumables to meet recurring military medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FCRG6?
SPE2DR26FCRG6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FCRG6 worth?
The government has obligated $17,021 on SPE2DR26FCRG6.
Is contract SPE2DR26FCRG6 an order under another contract?
Yes. SPE2DR26FCRG6 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRG6 competed?
The extent of competition for SPE2DR26FCRG6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award